Mediators of Inflammation

Table of Contents: 1996

  • Mediators of Inflammation -
  • Special Issue
  • Volume 5
  • - Article ID 975014

Plasma levels of immunosuppressive mediators during cardiopulmonary bypass

E. Borrelli | P. Giomarelli | ... | V. Bocci
  • Mediators of Inflammation -
  • Special Issue
  • Volume 5
  • - Article ID 210240

Time-resolved fluoroimmunoassay for bactericidal/permeability-increasing protein

J.-O. Häggblom | A. B. Jokilammi-Siltanen | ... | T. J. Nevalainen
  • Mediators of Inflammation -
  • Special Issue
  • Volume 5
  • - Article ID 917478

Serum levels of total IgE and soluble CD23 in bronchial asthma

G. Di Lorenzo | P. Mansueto | ... | C. Caruso
  • Mediators of Inflammation -
  • Special Issue
  • Volume 5
  • - Article ID 643741

The effect of an interleukin receptor antagonist (IL-1ra) on colonocyte eicosanoid release

G. S. Smith | C. Rieckenberg | ... | T. A. Miller
  • Mediators of Inflammation -
  • Special Issue
  • Volume 5
  • - Article ID 196865

Leukotriene C4 biosynthesis in isolated August rat peritoneal leukocytes

J. M. Huebner | R. R. Eversole | ... | L. J. Beuving
  • Mediators of Inflammation -
  • Special Issue
  • Volume 5
  • - Article ID 953147

Tumour necrosis factor α (TNF-α), interleukin-6 (IL-6) and their soluble receptors (sTNF-α-Rp55 and slL-6R) serum levels in systemic lupus erythematodes

E. Robak | A. Sysa-Jędrzejowska | ... | E. Waszczykowsk
  • Mediators of Inflammation -
  • Special Issue
  • Volume 5
  • - Article ID 682178

Role of transforming growth factor-β1 in down-regulating TNF production by alveolar macrophages during asbestos-induced pulmonary fibrosis

Irma Lemaire | Sophie Ouellet
  • Mediators of Inflammation -
  • Special Issue
  • Volume 5
  • - Article ID 318056

Changes in TNF and IL-6 production after diphtheria toxoid vaccination: drug modulation of the cytokine levels

A. L. Pukhalsky | M. S. Bliacher | ... | I. M. Fedorova
  • Mediators of Inflammation -
  • Special Issue
  • Volume 5
  • - Article ID 129686

Phosphodiesterase 4 inhibitors and db-cAMP inhibit TNF-α release from human mononuclear cells. Effects of cAMP and cGMP-dependent protein kinase inhibitors

A. Hichami | E. Boichot | ... | V. Lagente
  • Mediators of Inflammation -
  • Special Issue
  • Volume 5
  • - Article ID 845412

Cytokines as cellular communicators

R. Debets | H. F. J. Savelkoul
  • Mediators of Inflammation -
  • Special Issue
  • Volume 5
  • - Article ID 243174

Chemokines: structure, receptors and functions. A new target for inflammation and asthma therapy?

F. A. A. van Acker | H-P. Voss | H. Timmerman
  • Mediators of Inflammation -
  • Special Issue
  • Volume 5
  • - Article ID 174128

A blinded comparison of fluticasone propionate with budesonide via powder devices in adult patients with moderate-to-severe asthma: a clinical evaluation

N. Ringdal | P. Swinburn | ... | T. A. J. Harris
  • Mediators of Inflammation -
  • Special Issue
  • Volume 5
  • - Article ID 578521

Apoptotic cell death, detected ex vivo in peripheral blood lymphocytes of HIV-1 infected persons

L. F. te Velde | I. Vermes | ... | C. H. H. ten Napel
  • Mediators of Inflammation -
  • Special Issue
  • Volume 5
  • - Article ID 732614

Induction of annexin-1 at transcriptional and post-transcriptional level in rat brain by methylprednisolone and the 21-aminosteroid U74389F

P. H. Voermans | K. G. Go | ... | L. Parente
  • Mediators of Inflammation -
  • Special Issue
  • Volume 5
  • - Article ID 734054

Cell surface antigen expression by peripheral blood monocytes in allergic asthma: results of 2.5 years therapy with inhaled beclomethasone dipropionate

W. A. T. Slieker | P. Th. W. van Hal | ... | H. C. Hoogsteden
Mediators of Inflammation
 Journal metrics
See full report
Acceptance rate14%
Submission to final decision136 days
Acceptance to publication27 days
CiteScore7.700
Journal Citation Indicator0.570
Impact Factor4.6
 Submit Check your manuscript for errors before submitting

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.